Beyondspring Inc
NASDAQ:BYSI

Watchlist Manager
Beyondspring Inc Logo
Beyondspring Inc
NASDAQ:BYSI
Watchlist
Price: 1.51 USD -6.21% Market Closed
Market Cap: 63.3m USD

During the last 3 months Beyondspring Inc insiders have not bought any shares, and sold 546.5k USD worth of shares. The stock price has dropped by 15% over this period (open performance analysis).

The last transaction was made on Oct 17, 2025 by Cui Xiangmin , who sold 80.1k USD worth of BYSI shares.

Last Transactions:
Cui Xiangmin
$-80.1k
Cui Xiangmin
Chief Medical Officer
$-147.6k
Cui Xiangmin
$-29.6k
Cui Xiangmin
Chief Medical Officer
$-47k
Cui Xiangmin
Chief Medical Officer
$-182.5k
Cui Xiangmin
$-4.2k
Cui Xiangmin
Chief Medical Officer
$-7.2k
Cui Xiangmin
Chief Medical Officer
$-13.3k
Cui Xiangmin
$-3.8k
Cui Xiangmin
Chief Medical Officer
$-31.2k
Cui Xiangmin
Chief Medical Officer
$-1.1k
Cui Xiangmin
$-1k
Cui Xiangmin
$-4.7k
Cui Xiangmin
$-8.1k
Cui Xiangmin
$-875
Cui Xiangmin
$-1k
Cui Xiangmin
$-1.2k
Cui Xiangmin
$-3.8k
Cui Xiangmin
$-7.1k
Cui Xiangmin
$-9.9k
Cui Xiangmin
$-6.5k
Cui Xiangmin
$-9.2k
Cui Xiangmin
$-4.2k
Cui Xiangmin
$-1.6k
Cui Xiangmin
$-4.7k
Cui Xiangmin
$-1.3k
Cui Xiangmin
$-7.3k
Cui Xiangmin
$-15.8k
Cui Xiangmin
$-17.8k
Cui Xiangmin
$-13.7k
Cui Xiangmin
$-2.1k
Cui Xiangmin
$-1.5k
View All Transactions

During the last 3 months Beyondspring Inc insiders have not bought any shares, and sold 546.5k USD worth of shares. The stock price has dropped by 15% over this period (open performance analysis).

The last transaction was made on Oct 17, 2025 by Cui Xiangmin , who sold 80.1k USD worth of BYSI shares.

Sold
0-3
months
515.3k USD
1
3-6
months
394.9k USD
1
6-9
months
398.1k USD
1
9-12
months
0 USD
0
Bought
0-3
months
0
0 USD
3-6
months
0
0 USD
6-9
months
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

Beyondspring Inc
Insider Trading Chart

Beyondspring Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Beyondspring Inc
Last Insider Transactions

Global
Insiders Monitor

Beyondspring Inc
Glance View

Market Cap
60.9m USD
Industry
Biotechnology

BeyondSpring, Inc. engages in the the development and commercialization of immuno-oncology cancer therapies to improve clinical outcomes for patients who have high unmet medical needs. The company is headquartered in New York City, New York and currently employs 103 full-time employees. The company went IPO on 2017-03-09. The Company’s lead product Plinabulin, which is being studied as an anti-cancer agent in combination with docetaxel in advanced non-small cell lung cancer (NSCLC). The Plinabulin product is a marine-derived small-molecule selective immunomodulating microtubule-binding agent (SIMBA) with a range of immune activities. Its Plinabulin has the immune defense protein, GEF-H1, which leads to two effects: a durable anti-cancer benefits due to the maturation of dendritic cells resulting in activation of tumor antigen-specific T-cells to target cancer cells and early-onset action in chemotherapy-induced neutropenia (CIN) prevention after chemotherapy by boosting the number of hematopoietic stem/progenitor cells (HSPCs).

BYSI Intrinsic Value
Not Available

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top